Tortoise and hare racing to represent slow and fast healthcare adoption.

From Scurvy to Social Media: Why Healthcare Innovations Take a Tortoise's Pace (and How to Speed Things Up)

"Unraveling the mystery of slow progress in healthcare adoption—lessons from history and a call to action for faster change."


One of the most persistent challenges in healthcare is the time it takes for research findings to translate into everyday practice. It’s often estimated that it takes around 17 years for evidence to become mainstream. But why does it take so long, and why are some innovations adopted quickly while others languish for decades?

Think of it as a race between the hare and the tortoise. Some breakthroughs, like the impact of the Term Breech Trial on vaginal breech births, are adopted almost overnight. Others, like the recognition of the importance of midwifery continuity of care, crawl along despite strong evidence. This raises a critical question: How can we ensure that valuable research doesn't get stuck in the slow lane?

To understand this challenge, let's look back at a historical example. In 1749, James Lind, a Scottish surgeon in the Royal Navy, conducted an experiment demonstrating that citrus fruits could treat scurvy. His findings were published in 1753, but it took another sixty years before the Admiralty recommended that lemon juice be routinely issued to the entire fleet. Sixty years! What caused this delay, and what lessons can we learn from it?

AI Search Multiple angles on this topic

Healthcare Access and Community Impact

Healthcare access spans preventive services, essential health benefits, and dental coverage through plans listed on HealthCare.gov. Family HealthCare Network reports serving California's Central Valley with services ranging from obstetrics to dental care, while celebrating 50 years of care. In Fresno, Healthcare Centre of Fresno provides skilled nursing and rehabilitation services. Impact Healthcare states that its Fresno-area services aim to support recovery and add quality and value for patients, families, and the healthcare system.

Established Care Takes Time

Healthcare innovation generally moves through established clinical, regulatory, and operational processes before becoming routine practice. These methods can support safety and accountability, but they may also make adoption slower than technological change in less regulated fields. Results can vary across patients, institutions, and communities, so promising approaches typically require careful evaluation rather than immediate widespread use.

The Growth of Certified Home Health

Healthcare California is described as a proprietary, Medicare-certified home health care agency in Fresno, California. The agency was certified to participate in Medicare programs on March 30, 2005. A January 25, 2020 listing reported that it had received a 3.5-star rating. This example illustrates how home-based care can become incorporated into established Medicare-participating services.

The Tortoise and the Hare: A Tale of Two Speeds

Tortoise and hare racing to represent slow and fast healthcare adoption.

The story of scurvy highlights a common theme in healthcare: evidence alone is not enough to drive change. Lind's discovery was initially met with skepticism because the prevailing belief was that scurvy was a disease of putrefaction. This illustrates how existing beliefs and biases can hinder the acceptance of new evidence, even when it's based on rigorous research.

Contrast this with the rapid adoption of certain other practices. The Term Breech Trial, published in 2000, dramatically changed the management of breech births. Many clinicians immediately embraced the trial's findings, leading to a significant decrease in vaginal breech births. But why was this evidence accepted so readily?

  • Clear and Immediate Benefit: The Term Breech Trial presented a seemingly clear-cut solution to a perceived problem.
  • Reduced Risk (Perceived): Caesarean sections were often seen as a safer alternative to vaginal breech births, even though subsequent research has challenged this assumption.
  • Alignment with Existing Preferences: The trial's findings aligned with a growing trend toward more interventional approaches in childbirth.
AI Search Multiple angles on this topic

Evidence Before Adoption

Recent healthcare research is often interpreted cautiously because early findings may not predict performance in everyday clinical settings. Reviews can help compare results, identify limitations, and clarify whether an intervention is ready for broader use. The transition from promising evidence to routine care therefore commonly requires additional validation, implementation work, and monitoring.

Why Innovation Can Fail

A healthcare innovation may fall short even when its underlying idea appears promising. Barriers can include uncertain evidence, difficult implementation, limited resources, or poor fit with patients' and clinicians' needs. These risks mean that slower adoption is not necessarily resistance to progress; it can also reflect attempts to avoid preventable harm and wasted investment.

Different Paces of Change

Healthcare systems do not adopt new practices at a uniform speed. Differences in regulation, infrastructure, workforce capacity, funding, and patient populations can produce different outcomes across organizations. Comparing approaches is therefore most useful when it considers both measurable results and the conditions that shaped implementation.

The contrasting experiences of scurvy and breech births underscore the importance of factors beyond the evidence itself. These include the perceived benefits and risks, alignment with existing beliefs, and the influence of professional norms and preferences. But what about more complex interventions, like midwifery continuity of care?

Bridging the Gap: A Call to Action for Faster Change

So, how can we accelerate the translation of evidence into practice? The key lies in addressing the challenges on multiple levels. We need to plan for implementation from the outset of our research, engage with women as consumers and end-users, and collaborate with providers, policymakers, and health service leaders. By working together, we can identify roadblocks, find champions, and monitor progress to ensure that valuable innovations reach those who need them most. The challenge is clear: let’s transform healthcare, one tortoise into a hare, and ensure the best possible outcomes for mothers and babies in all settings.

AI Search Multiple angles on this topic

Balancing Speed and Trust

Healthcare innovation requires a balance between moving quickly and protecting patients. Faster adoption may expand access to useful tools, but insufficient testing or preparation can undermine confidence and outcomes. A durable path forward combines evidence, transparent decision-making, and attention to how changes work in real care settings.

The Next Phase of Innovation

Future healthcare advances are likely to depend not only on new discoveries but also on the ability to integrate them into ordinary care. Successful progress may require adaptable systems, trained professionals, reliable evaluation, and equitable access. The most useful innovations will be those that improve care without creating obstacles that prevent patients or providers from using them.

Innovation Within a Larger System

Healthcare innovation is shaped by broader system conditions rather than technology alone. Regulation, payment structures, staffing, infrastructure, and unequal access can all influence whether an improvement reaches patients. Addressing these conditions is essential if faster innovation is to produce broad public benefit rather than isolated gains.

Care That Reaches People

The value of healthcare innovation is ultimately measured by its effect on patients, families, and communities. Services that are technically advanced may still have limited impact if they are difficult to access or do not fit people's circumstances. Keeping human needs central can help ensure that faster progress remains compassionate, practical, and meaningful.

What the reported outcomes mean in context

  • 13% versus 14% of birthsFor midwife continuity of care, instrumental vaginal births were estimated at 13% compared with 14% under other models of care. The reported relative risk was 0.89; the evidence was rated moderate certainty.[1]Caveat: Moderate-certainty evidence
  • 28 minutes per weekIn four trials, physical activity increased by an average of 28 minutes per week, from a range of 10 to 47 minutes more per week. The reported effect was small, and the evidence was rated very low certainty.[2]Caveat: Small effect; very low-certainty evidence
  • 0.25 and −0.41In a meta-analysis of social media interventions for patients with cancer, quality of life improved by a reported effect size of 0.25. Anxiety symptoms also improved by a reported effect size of −0.41, while depressive symptoms did not improve.[3]

What these findings add to the adoption story

The continuity-of-care comparisons put specific outcomes behind the article’s mention of midwifery: the reported differences favor continuity models for instrumental vaginal birth and episiotomy, but the certainty differs between those outcomes. These results describe comparisons between care models; they do not by themselves explain how quickly either model is adopted.[1]

The social-media findings are outcome-specific rather than a single verdict on whether these interventions work: physical activity, quality of life, anxiety symptoms, and depressive symptoms did not all show the same pattern. The physical-activity result also carries very low certainty, so it offers limited assurance about the size of the effect.[2] [3]

How the sources measure translation and implementation

Estimates of the time from research to clinical practice have used different, partly overlapping measures of the process, so they do not necessarily describe an identical interval. Reviews have also found that studies often use different proxy measures, making their results difficult to aggregate, compare, or generalize.[4]

Translation models describe one or more gaps along the pathway from research to practice, but approaches define those gaps differently. As a result, two accounts of translation may not be directly comparable even when they use similar language.[4]

A synthesis of implementation considerations groups them into research and information sharing, intentional planning, organisational underpinnings, creating the clinical context, and facilitative training. This adds operational detail to the article’s emphasis on planning and collaboration, without establishing that any single consideration guarantees adoption.[5]

What remains unresolved about speed and impact

  • Because translation studies define and measure the pathway differently, how much of a reported delay reflects the same stage of change across different settings?[4]
  • Which implementation considerations matter most in a particular clinical context, and how do information sharing, organisational conditions, clinical context, and training interact during adoption?[5]

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What was the primary challenge James Lind faced in getting his scurvy cure adopted, and how does this relate to modern healthcare innovations?

The main obstacle James Lind encountered was the skepticism stemming from prevailing beliefs about scurvy being a disease of putrefaction. This resistance to new evidence, despite Lind's rigorous research, mirrors current challenges in healthcare. Modern innovations often face similar hurdles. Established beliefs, biases, and a reluctance to change existing practices can significantly delay the adoption of proven advancements, much like the initial resistance to citrus fruits for treating scurvy.

2

Why did the Term Breech Trial findings experience rapid adoption compared to midwifery continuity of care or James Lind's citrus fruit treatment for scurvy?

The swift acceptance of the Term Breech Trial's findings contrasted sharply with the slow uptake of James Lind's discovery and midwifery continuity of care due to several factors. The Term Breech Trial presented a clear solution to a perceived problem, aligning with a trend toward more interventional approaches. In contrast, Lind's work challenged existing beliefs, and the benefits of midwifery care, though supported by strong evidence, faced resistance rooted in established practices and professional preferences. Also, the swiftness of Caesarean section was perceived as a safer alternative.

3

How did the prevailing beliefs of the time impact the acceptance of James Lind's scurvy treatment?

Prevailing beliefs were a major roadblock. The predominant understanding was that scurvy resulted from putrefaction, which clashed with Lind's findings on citrus fruits. This mismatch created skepticism, slowing the acceptance of his evidence-based cure. This emphasizes how firmly entrenched beliefs can outweigh even strong scientific evidence in the initial phases of innovation adoption.

4

What are the key factors that have historically slowed down the adoption of proven healthcare innovations, and what can be done to speed up this process?

Several factors contribute to slow adoption, including the perception of benefits and risks, the alignment with existing beliefs, and the influence of professional norms. To accelerate this, we must proactively plan for implementation, engage end-users (like women in maternity care), and encourage collaboration among healthcare providers, policymakers, and health service leaders. Identifying roadblocks, finding supporters, and carefully monitoring progress are essential steps.

5

Can you explain the significance of the 17-year timeframe often cited for the mainstream adoption of healthcare evidence, and what does this mean for the future?

The 17-year timeframe represents the often-lengthy period it takes for research findings to become standard practice. This delay highlights inefficiencies in the healthcare system, as it means patients may not benefit from proven treatments and approaches for years. It underscores the urgency of accelerating innovation adoption. The future requires a shift toward proactive implementation strategies, collaborative efforts, and a focus on ensuring that valuable innovations, such as improved midwifery care, reach those who need them quickly.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.